A tough biodegradable elastomer.

Department of Chemical Engineering, 77 Massachusetts Avenue, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Nature Biotechnology (Impact Factor: 39.08). 07/2002; 20(6):602-6. DOI: 10.1038/nbt0602-602
Source: PubMed

ABSTRACT Biodegradable polymers have significant potential in biotechnology and bioengineering. However, for some applications, they are limited by their inferior mechanical properties and unsatisfactory compatibility with cells and tissues. A strong, biodegradable, and biocompatible elastomer could be useful for fields such as tissue engineering, drug delivery, and in vivo sensing. We designed, synthesized, and characterized a tough biodegradable elastomer from biocompatible monomers. This elastomer forms a covalently crosslinked, three-dimensional network of random coils with hydroxyl groups attached to its backbone. Both crosslinking and the hydrogen-bonding interactions between the hydroxyl groups likely contribute to the unique properties of the elastomer. In vitro and in vivo studies show that the polymer has good biocompatibility. Polymer implants under animal skin are absorbed completely within 60 days with restoration of the implantation sites to their normal architecture.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Biodegradation-induced inflammation in biodegradable scaffold materials is a critical problem to be addressed due to its potential inducement to tissue necrosis, granulomas, or tumor genesis. Here, a facile strategy for on-demand release of anti-inflammatory drugs and full-course inhibition of degradation-induced inflammation was demonstrated by simply loading an esterase-sensitive prodrug into a fibrous scaffold. In this study, drug release from the prodrug-loaded scaffolds showed an enzyme-triggered release process, which led to an initial moderate release of anti-inflammatory drugs and a later-stage degradation-synchronized drug release. This unique release kinetics ingeniously achieved on-demand drug therapy and efficient inhibition of inflammation throughout the biodegradation in vivo. More importantly, the prodrug-loaded scaffolds prepared with different biodegradable polymers (i.e., different biodegradation rates) all showed drug release kinetics that matched to the biodegradation rates and full-course inhibition of inflammation in vivo. Therefore, this method offered a general approach for on-demand release of anti-inflammatory drugs and efficient inhibition of inflammation throughout the biodegradation of different polymeric scaffolds. In addition, the release kinetics in our system showed potentials for "batch release" of multiple drugs in combination therapies as well as provided a feasible hint for the drug therapies of some other symptoms caused by in vivo biodegradation. Copyright © 2015 Elsevier Ltd. All rights reserved.
    Biomaterials 06/2015; 53. DOI:10.1016/j.biomaterials.2015.02.078 · 8.31 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Poly(glycerol sebacate) (PGS) is a thermally-crosslinked elastomer suitable for tissue regeneration due to its elasticity, degradability, and pro-regenerative inflammatory response. Pores in PGS scaffolds are typically introduced by porogen leaching, which compromises strength. Methods for producing fibrous PGS scaffolds are very limited. Electrospinning is the most widely used method for laboratory scale production of fibrous scaffolds. Electrospinning PGS by itself is challenging, necessitating a carrier polymer which can affect material properties if not removed. We report a simple electrospinning method to produce distinct PGS fibers while maintaining the desired mechanical and cytocompatibility properties of thermally crosslinked PGS. Fibrous PGS demonstrated 5 times higher tensile strength and increased suture retention compared to porous PGS foams. Additionally, similar modulus and elastic recovery were observed. A final advantage of fibrous PGS sheets is the ability to create multi-laminate constructs due to fiber bonding that occurs during thermal crosslinking. Taken together, these highly elastic fibrous PGS scaffolds will enable new approaches in tissue engineering and regenerative medicine. Copyright © 2015. Published by Elsevier Ltd.
    Acta Biomaterialia 02/2015; DOI:10.1016/j.actbio.2015.02.005 · 5.68 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Biobased elastomers (bioelastomers) with high strength and good biocompatibility have emerged as promising biomaterials for soft tissue engineering. In the present work, we synthesized a series of biobased copolyesters, converting semicrystalline copolyesters into elastomers by introducing isosorbide, a bicyclic carbohydrate-based diol. The molecular weights, polymer structures and thermal transitions of the synthesized bioelastomers were characterized by GPC, NMR, FTIR, TGA, DSC and WAXD. The composition, melting point, and crystallinity of the bioelastomers could be tuned by changing the content of isosorbide. Furthermore, high strength composites could be prepared by compositing the synthesized bioelastomers with nanosilica. To substantiate the potential biocompatibility of the reinforced bioelastomers, the cell adhesion and proliferation were evaluated, and the results indicated that the reinforced bioelastomers were essentially noncytotoxic. The combination of sustainability, high strength and noncytotoxicity makes these bioelastomers potential candidates for high-strength biomedical materials.
    RSC Advances 01/2014; 4(37):19462. DOI:10.1039/c3ra46727a · 3.71 Impact Factor

Full-text (2 Sources)

Available from
May 29, 2014